Search Results

Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)

• Source: A Phase 3, International, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Study the Efficacy, Immunogenicity, and Safety of the 9vHPV Vaccine, a Multivalent L1 Virus-like

Record details

HPV Immunological Markers of Cervical Persistent Infection and Oncogenesis (HPVImmuno)

• Authors : Daniele Lilleri, Principal Investigator

• Source: HPV Immunological Markers of Cervical Persistent Infection and Oncogenesis

Record details

Diagnostic Cervical Conization for Persistent Infection or Integration of HPV

• Authors : National Natural Science Foundation of China; Li Shuang, Professor

• Source: A Study of the Value of Diagnostic Cervical Conization for Persistent Infection or Integration of Human Papillomavirus

Record details

Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls

• Authors : Xiamen Innovax Biotech Co., Ltd; Center for Disease Control and Prevention, Sheyang County, Yancheng City, Jiangsu Province, China; Jun Zhang, professor

• Source: Long-term Effectiveness and Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Girls Aged 9-17 Years

Record details

Scaling Up Point-of-Care Hepatitis C Testing and Treatment in Canada (SCALE POCT)

• Authors : The University of New South Wales; Canadian Institutes of Health Research (CIHR); Jewish General Hospital ...

• Source: Scaling Up Point-of-Care Hepatitis C Testing and Treatment in Canada: A Multilevel Implementation Science Study of Clinical Processes, Barriers, Facilitators and Implementation Strategies

Record details

C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV

• Source: Phase 3, Randomized, Controlled, Open-label Study to Compare the Efficacy and Safety of Bemnifosbuvir-Ruzasvir Fixed-dose Combination (BEM/RZR FDC) Versus Sofosbuvir-Velpatasvir Fixed-dose Combination

Record details

A Rhinovirus Challenge Study to Investigate Exacerbations and Immune Responses in Bronchiectasis (BARRIER)

• Authors : Imperial College Healthcare NHS Trust

• Source: Human Bronchiectasis Rhinovirus Challenge to Define Immunopathogenesis of Exacerbation

Record details

C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV

• Source: An Evaluation of Bemnifosbuvir-Ruzasvir (BEM/RZR) Versus Sofosbuvir-Velpatasvir (SOF/VEL) for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in a Phase 3

Record details

Evaluation of Different Medicaments in the Management of Necrotic Primary Molars by Lesion Sterilization and Tissue Repair

• Authors : Dina Ehab Abdel Razik Kamel, Assistant Lecturer of Pediatric Dentistry

• Source: Nano-based Medicaments Versus Double Antibiotic Paste in Managing Non-vital Primary Molars: A Randomized Clinical Trial and In-Vitro Study

Record details

Efficacy and Safety of Dalbavancin As Suppressive Therapy (DALBA-SAT)

• Source: Efficacy and Safety of Dalbavancin As Suppressive Therapy

Record details